STOCK TITAN

Janus Henderson Reports >7% Passive Ownership in JANX (13G/A)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Janus Henderson Group plc reports a passive institutional stake in Janux Therapeutics, Inc. common stock. The filing lists an aggregate beneficial ownership of 4,460,332 shares (7.5% of the class) attributed to the reporting person, while Item 4 separately identifies JHIUS as the beneficial owner of 4,379,232 shares (7.4%). The report shows shared voting and dispositive power over the shares and classifies the reporting person with reporting types IA and HC.

The filing states the shares are held in the ordinary course of business and not with the purpose of changing or influencing issuer control, and discloses that JHIUS, JHIUKL and JHIAIFML are indirect subsidiaries acting as registered investment advisers to managed portfolios.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: A material passive stake (~7.4-7.5%) by a large asset manager; signals institutional interest but no control intent.

Janus Henderson's position exceeds the 5% threshold, making it a material, reportable holding for Janux (JANX). The filing is a Schedule 13G/A, indicating a passive investment posture; the certification explicitly states the securities "were not acquired for the purpose of changing or influencing control." For investors, institutional ownership at this scale can support liquidity and may reflect confidence from professional managers, but it does not signal strategic influence or an activist campaign. Note the filing lists two close but different share counts in separate sections, which warrants attention for reconciliation.

TL;DR: Ownership is reportable and passive; governance implications are limited absent intent to influence control.

The Schedule 13G/A classification and the signer’s certification indicate a non-control, advisory role for the reporting group. As such, there are no immediate governance or control changes implied by this filing. The disclosure that indirect subsidiaries are registered investment advisers managing portfolios clarifies custodial and voting arrangements. The discrepancy between the aggregate amount (4,460,332) and the Item 4 figure (4,379,232) should be clarified in subsequent filings or exhibits to ensure transparency about exact holdings and voting authority.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance, CCO
Date:08/14/2025
Exhibit Information

POWER OF ATTORNEY The undersigned, Janus Henderson Group plc ("the Company"), does hereby make, constitute and appoint each of Kristin Mariani and Caroline Barotti acting severally, as its true and lawful attorneys in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Forms 13D, 13F, 13G and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 9th day of December, 2022. Janus Henderson Group plc By: /s/ Michelle Rosenberg Name: Michelle Rosenberg Title: General Counsel and Company Secretary

Janux Therapeutics, Inc.

NASDAQ:JANX

JANX Rankings

JANX Latest News

JANX Latest SEC Filings

JANX Stock Data

860.72M
54.05M
6.59%
109.98%
13.39%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO